# Peripheral Neuropathies and Disorders
**Type:** Topics
**Canonical URL:** https://scholariq.org/topics/peripheral-neuropathies-and-disorders/
## Facts
| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on Guillain-Barré syndrome and related neuropathies, including chronic inflammatory demyelinating polyradiculoneuropathy. It covers the pathogenesis, diagnosis, treatment, and prognosis of these neurological disorders, with a particular emphasis on the role of intravenous immunoglobulin therapy. The cluster also explores the autoimmune nature of these neuropathies and their association with specific antibodies and infections. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11735 |
| Works | 232 |
## Topic papers all
Showing 15 of 232.
- [International consensus diagnostic criteria for neuromyelitis optica spectrum disorders](https://scholariq.org/papers/international-consensus-diagnostic-criteria-for-neuromyelitis-optica-spectrum/)
- [A clinical approach to diagnosis of autoimmune encephalitis](https://scholariq.org/papers/a-clinical-approach-to-diagnosis-of-autoimmune-encephalitis/)
- [Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients](https://scholariq.org/papers/antiphospholipid-syndrome-clinical-and-immunologic-manifestations-and-patterns/)
- [Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia](https://scholariq.org/papers/antibodies-to-kv1-potassium-channel-complex-proteins-leucine-rich-glioma/)
- [Development of a multiple sclerosis functional composite as a clinical trial outcome measure](https://scholariq.org/papers/development-of-a-multiple-sclerosis-functional-composite-as-a-clinical-trial/)
- [Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies](https://scholariq.org/papers/auto-antibodies-to-the-receptor-tyrosine-kinase-musk-in-patients-with-myasthenia/)
- [Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria](https://scholariq.org/papers/diagnosis-of-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease/)
- [Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis](https://scholariq.org/papers/stages-of-ptdp-43-pathology-in-amyotrophic-lateral-sclerosis/)
- [N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes](https://scholariq.org/papers/n-methyl-d-aspartate-antibody-encephalitis-temporal-progression-of-clinical-and/)
- [The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment](https://scholariq.org/papers/the-multiple-sclerosis-functional-composite-measure-msfc-an-integrated-approach/)
- [MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome](https://scholariq.org/papers/mog-igg-in-nmo-and-related-disorders-a-multicenter-study-of-50-patients-part-2/)
- [A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease](https://scholariq.org/papers/a-randomized-trial-of-plasma-exchange-in-acute-central-nervous-system/)
- [A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis](https://scholariq.org/papers/a-longitudinal-study-of-abnormalities-on-mri-and-disability-from-multiple/)
- [Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders](https://scholariq.org/papers/distinction-between-mog-antibody-positive-and-aqp4-antibody-positive-nmo/)
- [Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study](https://scholariq.org/papers/safety-and-efficacy-of-eculizumab-in-anti-acetylcholine-receptor-antibody/)
## Topic primary papers
Showing 15 of 20.
- [Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain–Barré syndrome](https://scholariq.org/papers/carbohydrate-mimicry-between-human-ganglioside-gm1-and-i-campylobacter-jejuni-i/)
- [Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy](https://scholariq.org/papers/sequential-electrodiagnostic-abnormalities-in-acute-inflammatory-demyelinating/)
- [Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features](https://scholariq.org/papers/acquired-inflammatory-demyelinating-polyneuropathies-clinical-and/)
- [Regional variation of Guillain-Barré syndrome](https://scholariq.org/papers/regional-variation-of-guillain-barre-syndrome/)
- [Characterization of IgG4 anti‐neurofascin 155 antibody‐positive polyneuropathy](https://scholariq.org/papers/characterization-of-igg4-anti-neurofascin-155-antibody-positive-polyneuropathy/)
- [Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh](https://scholariq.org/papers/axonal-variant-of-guillain-barre-syndrome-associated-with-i-campylobacter-i/)
- [Guillain-Barré Syndrome and Preceding Infection with Campylobacter, Influenza and Epstein-Barr Virus in the General Practice Research Database](https://scholariq.org/papers/guillain-barre-syndrome-and-preceding-infection-with-campylobacter-influenza-and/)
- [Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial](https://scholariq.org/papers/safety-and-efficacy-of-eculizumab-in-guillain-barre-syndrome-a-multicentre/)
- [Epidemiology ofCampylobacter jejuniIsolated from Patients with Guillain-Barre and Fisher Syndromes in Japan](https://scholariq.org/papers/epidemiology-of-i-campylobacter-jejuni-i-isolated-from-patients-with-guillain/)
- [Guillain–Barré syndrome in low-income and middle-income countries: challenges and prospects](https://scholariq.org/papers/guillain-barre-syndrome-in-low-income-and-middle-income-countries-challenges-and/)
- [An International Perspective on Preceding Infections in Guillain-Barré Syndrome](https://scholariq.org/papers/an-international-perspective-on-preceding-infections-in-guillain-barre-syndrome/)
- [Current treatment practice of Guillain-Barré syndrome](https://scholariq.org/papers/current-treatment-practice-of-guillain-barre-syndrome/)
- [Guillain-Barré Syndrome Associated with COVID-19 Vaccination](https://scholariq.org/papers/guillain-barre-syndrome-associated-with-covid-19-vaccination/)
- [Very early electrodiagnostic findings in Guillain‐Barré syndrome](https://scholariq.org/papers/very-early-electrodiagnostic-findings-in-guillain-barre-syndrome/)
- [Link between peripheral neuropathy and monoclonal dysglobulinemia: a study of 66 cases](https://scholariq.org/papers/link-between-peripheral-neuropathy-and-monoclonal-dysglobulinemia-a-study-of-66/)
---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.